Search

Author/Creator Maas, Brian M.

2. A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults. Issue 5 (30th October 2020)

Authors:
Aliprantis, Antonios O.; Wolford, Dennis; Caro, Luzelena; Maas, Brian M.; Ma, Hua; Montgomery, Diana L.; Sterling, Laura M.; Hunt, Allen; Cox, Kara S.; Vora, Kalpit A.; Roadcap, Brad A.; Railkar, Radha A.; Lee, Andrew W.; Stoch, S. Aubrey; Lai, Eseng
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 5(2021)
Page Start:
556
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK‐1654 in healthy Japanese adults. Issue 7 (17th May 2022)

Authors:
Orito, Yuji; Otani, Naoyuki; Matsumoto, Yuki; Fujimoto, Katsukuni; Oshima, Nobuyuki; Maas, Brian M.; Caro, Luzelena; Aliprantis, Antonios O.; Cox, Kara S.; Tokumaru, Osamu; Kodama, Masaaki; Kudo, Hideo; Imai, Hiromitsu; Uemura, Naoto
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 7(2022)
Page Start:
1753
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19. Issue 11 (23rd September 2022)

Authors:
Nakamura, Keisuke; Fujimoto, Katsukuni; Hasegawa, Chihiro; Aoki, Ikuo; Yoshitsugu, Hiroyuki; Ugai, Hiroyuki; Yatsuzuka, Naoyoshi; Tanaka, Yoshiyuki; Furihata, Kenichi; Maas, Brian M.; Wickremasingha, Prachi K.; Duncan, Kelly E.; Iwamoto, Marian; Stoch, Selwyn A.; Uemura, Naoto
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 11(2022)
Page Start:
2697
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗